Specifically, in the non-rTBI population, tau pathology appears in 15–30% of individuals in their 20s and 30s and 40–45% of individuals in their 40s, as Braak stage I-II, stages which are far dissociated from clinical presentation of cognitive decline [16, 100]. This evidence concerns the gene MAPT and Mental deterioration.